Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Nutrition 21, Inc. (NasdaqNM:NXXI)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Location
4 Manhattanville Road
Purchase, NY 10577
Phone: (914) 701-4500
Fax: (914) 696-0863
Email: mail@ambiinc.com
Employees (last reported count): 42
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 37%
·Over the last 6 months:
 · 4 insider buys; 45.0K shares (0.4% of insider shares)
·Institutional: 4% (7% of float)
(20 institutions)
·Net Inst. Selling: 35.0K shares (+2.55%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Nutrition 21, Inc., formerly AMBI, Inc., concentrates its business primarily on research, development, manufacturing and sales of proprietary nutrition products. The Company supports the value of its Nutrition Products with pharmaceutical-type clinical trials and patent filings. The Company's Nutrition Products are developed for consumers concerned primarily about cardiovascular health, weight control and blood glucose control. Nutrition 21also develops, manufactures and markets essential trace elements used as Ingredient Products in nutritional supplements. Currently, the Company's primary product is chromium picolinate. On April 3, 2000, the Company launched NutritionU.com, Inc., an Internet company. NutritionU.com is an online nutrition education network that will offer patients and consumers interactive courses designed to increase their knowledge of nutrition in order to improve or maintain their health.
More from Market Guide: Expanded Business Description

Financial Summary
Nutrition 21, Inc. is engaged in research, development, manufacturing, and sales of Nutrition Products. For the nine months ended 3/31/01, revenues decreased 31% to $17.9 million. Net income applicable to Common fell 97% to $212 thousand. Revenues reflect lower selling prices of chromium picolinate subsequent to the expiration of a patent in August 2000. Earnings also suffered from lower profit margins due to product mix, and $2.4 million in restructuring charges.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 5,109; after tax earnings were 716. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

John Gutfreund, 70
Chairman
--  
Gail Montgomery
Pres, CEO, Director
--  
Gerald Shapiro, 53
CFO, VP of Fin. and Admin.
$213K
Benjamin Sporn, 62
Sr. VP, Gen. Counsel and Sec.
265K
Jonathan De la Harpe, Ph.D., 55
Sr. VP, Commercial Operations
213K
Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:NXXIAs of 31-Aug-2001
Price and Volume
52-Week Low
on 2-Jan-2001
$0.656
Recent Price$0.96 
52-Week High
on 5-Sep-2000
$2.125
Beta0.27 
Daily Volume (3-month avg)41.4K
Daily Volume (10-day avg)17.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-52.0%
52-Week Change
relative to S&P500
-35.6%
Share-Related Items
Market Capitalization$31.0M
Shares Outstanding32.3M
Float20.3M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$0.94 
Earnings (ttm)$0.03 
Earnings (mrq)$0.02 
Sales (ttm)$0.70 
Cash (mrq*)$0.14 
Valuation Ratios
Price/Book (mrq*)1.02 
Price/Earnings (ttm)38.40 
Price/Sales (ttm)1.38 
Income Statements
Sales (ttm)$23.0M
EBITDA (ttm*)$1.94M
Income available to common (ttm)$927.0K
Profitability
Profit Margin (ttm)4.6%
Operating Margin (ttm)-7.4%
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)2.75%
Return on Equity (ttm)3.19%
Financial Strength
Current Ratio (mrq*)2.02 
Debt/Equity (mrq*)0.05 
Total Cash (mrq)$5.36M
Short Interest
As of 8-Aug-2001
Shares Short12.0K
Percent of Float0.1%
Shares Short
(Prior Month)
18.0K
Short Ratio0.63 
Daily Volume19.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.